Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for Type 1 Diabetes
Sites in Atlanta +6 more locations
Sponsor: Indiana University
Sex: All·Age: 18+
Code: NCT07676565·Recruiting·Listed Jun 2026
Clinical Trials at Emory University
As of September 2026, 188 paid clinical trials are recruiting at Emory University, located at 1364 CLIFTON RD NE, ATLANTA, GA 30322-1064, phone (404) 686-7041 in Atlanta, Georgia. Active studies at this site cover conditions such as Multiple Myeloma, Breast Cancer and Sickle Cell Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Atlanta
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Inspiring Seniors Towards Exercise Promotion - 2
for Old Age
1 location in Atlanta
Sponsor: Emory University
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07629739·Recruiting·Listed Jun 2026
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
for Myelofibrosis
Drug: Ruxolitinib
Sites in Atlanta +29 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT07623161·Phase 3·Recruiting·Listed Jun 2026
191 clinical trials at Emory University
·Clear filters· Get a weekly email when new trials open in Atlanta, GA.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Atlanta, Thomasville +110 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for Ventricular Arrythmia
Sites in Atlanta +26 more locations
Sponsor: AtaCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT07324031·Recruiting·Listed Jan 2026
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
Sites in Atlanta, Macon +45 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Atlanta +7 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07266441·Phase 2·Recruiting·Listed Dec 2025
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Atlanta +38 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Atlanta +33 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Atlanta, Macon +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
for Chronic Kidney Disease
Drug: Empagliflozin
Sites in Atlanta +26 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 2 - 17
Code: NCT07107945·Phase 3·Recruiting·Listed Aug 2025
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
for Non-muscle Invasive Bladder Cancer
Sites in Atlanta +53 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07206225·Phase 1·Recruiting·Listed Oct 2025
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
Sites in Atlanta, Augusta +43 more locations
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for Multiple Myeloma
Sites in Atlanta +27 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05201781·Phase 4·Recruiting·Listed Jan 2022
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
Sites in Atlanta +45 more locations
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Drug: Avacopan
Sites in Atlanta +57 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
for Bronchiectasis
Sites in Atlanta, Augusta +14 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT06872892·Phase 3·Recruiting·Listed Mar 2025
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for Mitral Valve Regurgitation
Sites in Atlanta +66 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18+
Code: NCT03242642·Recruiting·Listed Aug 2017
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for Intermediate Risk Non-Muscle Invasive Bladder Cancer
Drug: Nadofaragene Firadenovec
Sites in Atlanta +49 more locations
Sponsor: Ferring Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06510374·Phase 3·Recruiting·Listed Jul 2024
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostate Cancer
Sites in Atlanta +20 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT04221542·Phase 1·Recruiting·Listed Jan 2020
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for Endometrial Adenocarcinoma
Sites in Atlanta +41 more locations
Sponsor: Acrivon Therapeutics
Sex: Female·Age: 18+
Code: NCT05548296·Phase 2·Recruiting·Listed Sep 2022
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for Adjustment Disorder
Sites in Atlanta +31 more locations
Sponsor: Reunion Neuroscience Inc
Sex: All·Age: 18 - 80
Code: NCT07002034·Phase 2·Recruiting·Listed Jun 2025
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
Sites in Atlanta, Augusta +29 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for Colorectal Cancer
Sites in Atlanta +31 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT06562543·Phase 4·Recruiting·Listed Aug 2024
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Sites in Atlanta, Columbus +68 more locations
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for Superficial Bladder Cancer
Sites in Atlanta, Augusta +46 more locations
Sponsor: enGene, Inc.
Sex: All·Age: 18+
Code: NCT04752722·Phase 1, Phase 2·Recruiting·Listed Feb 2021
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
Sites in Atlanta +46 more locations
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for Myelofibrosis
Sites in Atlanta +29 more locations
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
for Type 1 Diabetes Mellitus
Sites in Atlanta +37 more locations
Sponsor: COUR Pharmaceutical Development Company, Inc.
Sex: All·Age: 12 - 35
Code: NCT06783309·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for Platinum-resistant Ovarian Cancer
Drug: Bevacizumab
Sites in Atlanta +32 more locations
Sponsor: Genelux Corporation
Sex: Female·Age: 18+
Code: NCT05281471·Phase 3·Recruiting·Listed Mar 2022
ELEVATE-HFpEF Clinical Study
for Heart Failure With Preserved Ejection Fraction (HFpEF)
Sites in Atlanta +25 more locations
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All·Age: 40+
Code: NCT06678841·Recruiting·Listed Nov 2024
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Drug: Nadofaragene Firadenovec
Sites in Atlanta +38 more locations
Sponsor: Ferring Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06545955·Phase 3·Recruiting·Listed Aug 2024
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for Treatment Resistant Depression
Sites in Atlanta, Marietta +51 more locations
Sponsor: LivaNova
Sex: All·Age: 18+
Code: NCT03887715·Recruiting·Listed Mar 2019
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for Prostate Cancer
Sites in Atlanta, Athens +25 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06780670·Phase 2, Phase 3·Recruiting·Listed Jan 2025
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for High-Risk Non-Muscle-Invasive Bladder Cancer
Sites in Atlanta +60 more locations
Sponsor: CG Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06567743·Phase 2·Recruiting·Listed Aug 2024
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for Metastatic Head-and-neck Squamous-cell Carcinoma
Sites in Atlanta +24 more locations
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06064877·Phase 3·Recruiting·Listed Oct 2023
Caris Biorepository Research Protocol
for Cancer
Sites in Atlanta, Dublin +36 more locations
Sponsor: Caris Science, Inc.
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT01499394·Recruiting·Listed Dec 2011
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
for Chronic Graft-versus-host-disease
Sites in Atlanta +12 more locations
Sponsor: Syndax Pharmaceuticals
Sex: All·Age: 2+
Code: NCT04710576·Phase 2·Recruiting·Listed Jan 2021
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
for Aortic Dissection
Sites in Atlanta +23 more locations
Sponsor: Endospan Ltd.
Sex: All·Age: 18+
Code: NCT04471909·Recruiting·Listed Jul 2020
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
for Type 2 Diabetes Mellitus
Sites in Atlanta +10 more locations
Sponsor: Insulet Corporation
Sex: All·Age: 14 - 75
Code: NCT07579702·Recruiting·Listed May 2026
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Drug: Teclistamab
Sites in Atlanta +34 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07518186·Phase 3·Recruiting·Listed Apr 2026
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
for Small Cell Lung Cancer (SCLC)
Drug: Atezolizumab
Sites in Atlanta +16 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07472517·Phase 3·Recruiting·Listed Mar 2026
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for Myelodysplastic Syndrome
Sites in Atlanta +24 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT07422480·Phase 3·Recruiting·Listed Feb 2026
Common conditions studied in Atlanta
- Multiple Myeloma (28 active studies)
- Breast Cancer (21 active studies)
- Sickle Cell Disease (19 active studies)
- Schizophrenia (18 active studies)
- Acute Myeloid Leukemia (16 active studies)
- Heart Failure (15 active studies)
Leading research sponsors in Atlanta
- Emory University
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Atlanta?
There are approximately 1,472 recruiting clinical trials in Atlanta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Atlanta pay participants?
Most recruiting trials in Atlanta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Atlanta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Atlanta?
The most common conditions under active study in Atlanta include Multiple Myeloma (28), Breast Cancer (21), Sickle Cell Disease (19), Schizophrenia (18), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Atlanta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Atlanta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Atlanta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Atlanta?
Recruiting research sites in Atlanta include Emory University, Emory University Hospital/Winship Cancer Institute, Emory University Hospital Midtown, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Atlanta right now?
The largest active categories in Atlanta are Cancer & tumors (452), Cardiovascular (103), Neurology & pain (80). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Emory University?
Emory University is located at 1364 CLIFTON RD NE, ATLANTA, GA 30322-1064. Use the Google Maps link in the intro above to get directions.
How do I contact Emory University?
You can reach Emory University by phone at (404) 686-7041. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Georgia
Decatur, GA(182)Augusta, GA(178)Savannah, GA(129)Marietta, GA(93)Macon, GA(71)Columbus, GA(63)Lawrenceville, GA(58)Athens, GA(56)Newnan, GA(51)Gainesville, GA(50)Johns Creek, GA(35)Stockbridge, GA(32)Snellville, GA(25)Sandy Springs, GA(22)Woodstock, GA(22)Fayetteville, GA(21)Union City, GA(19)Albany, GA(17)Canton, GA(16)Roswell, GA(16)Brunswick, GA(15)Duluth, GA(15)Tucker, GA(14)Conyers, GA(12)Cumming, GA(12)Norcross, GA(12)Thomasville, GA(12)Douglasville, GA(11)East Point, GA(11)Peachtree Corners, GA(11)Suwanee, GA(11)Cordele, GA(10)Hinesville, GA(10)Alpharetta, GA(9)Dalton, GA(9)Stone Mountain, GA(9)Austell, GA(8)Riverdale, GA(8)Valdosta, GA(8)Braselton, GA(7)Rincon, GA(7)Dunwoody, GA(6)Morrow, GA(6)Smyrna, GA(6)Tifton, GA(6)Acworth, GA(5)Cartersville, GA(5)Lilburn, GA(5)Buford, GA(4)Carrollton, GA(4)Dublin, GA(4)Jasper, GA(4)Kennesaw, GA(4)Peachtree City, GA(4)Ringgold, GA(4)Rome, GA(4)Warner Robins, GA(4)Adairsville, GA(3)College Park, GA(3)Evans, GA(3)